Stephen Buckley Jr., Director at Tokai Pharmaceuticals Inc (TKAI), bought 3,000 shares at $11.25 ($34K) on 2015-11-11, disclosed to the SEC on 2015-11-12.
Open-market purchase of $34k TKAI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ENTA | BUY | 2014-08-15 | $39K | — | Filing → |